Follow RSS for latest reports on this topicInflammatory Bowel Disease (IBD) - Market Research and Reports

Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2020

Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2020SummaryGlobalData's clinical trial report, “Inflammatory Bowel Disease Global Clinical Trials Review, H2, 2020 provides an overview of Inflammatory Bowel Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on Inflammatory Bowel Disease. Report includes an overview of trial numbers ...Read More >>>

Published:
2020-08-14

Published by: Global Data

Prices Starting From:
$2500

Short Bowel Syndrome - Pipeline Review, H1 2020

Short Bowel Syndrome - Pipeline Review, H1 2020SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome - Pipeline Review, H1 2020, provides an overview of the Short Bowel Syndrome (Gastrointestinal) pipeline landscape.Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the sma...Read More >>>

Published:
2020-06-30

Published by: Global Markets Direct

Prices Starting From:
$2000

Inflammatory Bowel Disease (IBD) Treatment Market, By Type (Crohn’s Disease, and Ulcerative Colitis), By Route of Administration (Oral, and Injectable), By Distribution Channel (Online Pharmacy, Retail Pharmacy, and Hospital Pharmacy), and By Geography (NA, EU, APAC, LATAM and MEA) – Analysis, Share, Trends, Size, & Forecast from 2020 – 2026- COVID-19 Updated

REPORT HIGHLIGHTInflammatory Bowel Disease (IBD) Treatment market was valued at USD 15.87 billion by 2019, growing with 4.1% CAGR during the forecast period, 2020-2026Market DynamicsA rise in the number of drugs available in clinical tests, growing prevalence of inflammatory bowel disease (IBD), and rising government initiatives related to the analysis of the causes and effective novel drug develo...Read More >>>

Published:
2020-06-01

Published by: AnalystView

Prices Starting From:
$3250

Autoimmune Disease Diagnosis Market by Product (Consumables, Assay Kits, Instruments), Test Type (Inflammatory Markers, Routine Laboratory Tests), Disease (RA, SLE, Thyroiditis, Scleroderma), End User (Hospitals, Clinical Labs) – Global Forecast to 2025

“The global autoimmune disease diagnosis market size is projected to register a CAGR of 8.9% during the forecast period.”The global autoimmune disease diagnosis market size is projected to reach USD 6.3 billion by 2025 from USD 4.1 billion in 2020, at a CAGR of 8.9%. Growth in this industry is driven by the rising incidence of chronic diseases and the increasing demand for autoimmune disease d...Read More >>>

Published:
2020-04-10

Published by: MarketsandMarkets

Prices Starting From:
$4950

Short Bowel Syndrome - Pipeline Review-2038

Firstview Insight's Short Bowel Syndrome - Pipeline Review-2038 provides an overview of the pipeline landscape of Short Bowel Syndrome It provides comprehensive insights of all the clinical and non-clinical therapeutics in development with detailed description about the collaborations; deals; designations; patent information etc.These reports encourage the clients in distinguishing the upcoming a...Read More >>>

Published:
2019-12-27

Published by: First View Insight

Prices Starting From:
$1250

Irritable Bowel Syndrome - Pipeline Review, H2 2019

Irritable Bowel Syndrome - Pipeline Review, H2 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H2 2019, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that affects large intestine (colon). Sym...Read More >>>

Published:
2019-12-16

Published by: Global Markets Direct

Prices Starting From:
$2000

Short Bowel Syndrome - Pipeline Review, H2 2019

Short Bowel Syndrome - Pipeline Review, H2 2019SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome - Pipeline Review, H2 2019, provides an overview of the Short Bowel Syndrome (Gastrointestinal) pipeline landscape.Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the sma...Read More >>>

Published:
2019-12-16

Published by: Global Markets Direct

Prices Starting From:
$2000

Lymphedema Diagnostics Market by Technology (Lymphoscintigraphy, MRI, Near IR Fluorescence Imaging, Ultrasound), Disease Type (Cancer, Inflammatory Diseases, Cardiovascular, Filariasis), End User (Hospitals, Diagnostic Centers) - Global Forecasts to 2024

“The lymphedema diagnostics market is projected to grow at a CAGR of 7.4% during the forecast period.”The global lymphedema diagnostics market is projected to reach USD 35 million by 2024 from USD 24 million in 2019, at a CAGR of 7.4%. The major factors driving the growth of this market include the increasing global prevalence of cancer and lymphedema; technological advancements in diagnostic ...Read More >>>

Published:
2019-10-25

Published by: MarketsandMarkets

Prices Starting From:
$5650

Inflammatory Bowel Disease- Market Insights, Epidemiology and Market Forecast 2028

Report Summary Inflammatory Bowel Disease- Market Insights, Epidemiology and Market Forecast 2028 report provides the detailed overview of the disease and in depth understanding of historical and forecasted epidemiology. It highlights the existing treatment patterns, potential upcoming drugs and also identifies best of the market opportunities by providing the current and forecasted market revenu...Read More >>>

Published:
2019-07-26

Published by: MIReports

Prices Starting From:
$5980

Global Rheumatology Therapeutics Market Size study, by Disease Type (Rheumatoid Arthritis, Ankylosing Spondylitis, Osteoarthritis, Lupus, Gout, Others), by Drug Type (Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Disease Modifying Anti-Rheumatic Drugs (DMARDs), Corticosteroids, Others), by Distribution Channel (Retail Pharmacy, Online Pharmacy, Hospitals, Others) and Regional Forecas

Global Rheumatology Therapeutics Market valued approximately USD 44.38 billion in 2018 is anticipated to grow with a healthy growth rate of more than 2.73% over the forecast period 2019-2026. The Rheumatology Therapeutics Market is continuously growing in the global scenario at significant pace. Rheumatology therapeutics market consists of therapeutics used for the treatment of rheumatic disorders...Read More >>>

Published:
2019-06-25

Published by: Bizwit Research and Consulting

Prices Starting From:
$3950

2019 Pelvic Inflammatory Disease (Pelvic Infections) Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

The global clinical trial report- “2019 Pelvic Inflammatory Disease (Pelvic Infections) Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Pelvic Inflammatory Disease (Pelvic Infections). It presents in-depth analysis of Pelvic Inflammatory Disease (Pelvic Infections) clinical trials across markets and companies. The research work is for providing compl...Read More >>>

Published:
2019-04-24

Published by: VPA Research

Prices Starting From:
$1799

Irritable Bowel Syndrome - Pipeline Drugs and Companies, Q2 2019

Summary Irritable Bowel Syndrome pipeline research report is a part of our 300+ Pharmaceutical and Healthcare disease pipeline report series. It provides detailed insights into Irritable Bowel Syndrome R&D activities including pipeline candidates, grants, developments, investments, technological advancements, and progress.Extensive Coverage of Pipeline CandidatesThe Irritable Bowel Syndrome report...Read More >>>

Published:
2019-04-08

Published by: VPA Research

Prices Starting From:
$1799

Short Bowel Syndrome - Pipeline Drugs and Companies, Q2 2019

Summary Short Bowel Syndrome pipeline research report is a part of our 300+ Pharmaceutical and Healthcare disease pipeline report series. It provides detailed insights into Short Bowel Syndrome R&D activities including pipeline candidates, grants, developments, investments, technological advancements, and progress.Extensive Coverage of Pipeline CandidatesThe Short Bowel Syndrome report covers all ...Read More >>>

Published:
2019-04-08

Published by: VPA Research

Prices Starting From:
$1799

Irritable Bowel Syndrome - Pipeline Review, H2 2018

Irritable Bowel Syndrome - Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H2 2018, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that affects large intestine (colon). Sym...Read More >>>

Published:
2018-11-13

Published by: Global Markets Direct

Prices Starting From:
$2000

Competitor Landscape: Inflammatory Bowel Disease (IBD)

Competitor Landscape: Inflammatory Bowel Disease (IBD)SummarySociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the IBD market, analysis of current & potential future product positioning, and forecast approval dates (by quarter) for candidates in Phase II development, or higher - - Executive Summary: Contains analysis of key market events th...Read More >>>

Published:
2018-09-28

Published by: Global Data

Prices Starting From:
$6400

Digital Landscape: Inflammatory Bowel Disease

Digital Landscape: Inflammatory Bowel DiseaseSummaryThe Digital Landscape Inflammatory Bowel Disease report analyzes digital activities undertaken by pharma in support of disease-modifying therapies for mild-to-moderate, and moderate-to-severe Crohn’s disease and ulcerative colitis (UC).Key Highlights- US Patients: AbbVie offers the strongest support for IBD patients in the US, particularly bran...Read More >>>

Published:
2018-09-06

Published by: Global Data

Prices Starting From:
$6000

Inflammatory Bowel Diseases: Opportunity Assessments, Epidemiology Forecast, Market Dynamics, Pipeline Analysis, H1 2020

GervanoRA’s Pipeline Drug Analytics Report Inflammatory Bowel Diseases Pipeline Drugs: Opportunity Assessments, Epidemiology Forecast, Market Dynamics and Pipeline Analysis H2 2020 provides a detailed overview on Inflammatory Bowel Diseases Competitive Space. Report provides deep insights on pipeline analytics outlook, drivers, restraints and unmet needs of Inflammatory Bowel Diseases pipeline...Read More >>>

Published:
2018-08-12

Published by: Gervano R A

Prices Starting From:
$1250

Short Bowel Syndrome Global Clinical Trials Review, H2, 2018

Short Bowel Syndrome Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, “Short Bowel Syndrome Global Clinical Trials Review, H2, 2018 provides an overview of Short Bowel Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials on Short Bowel Syndrome. Report includes an overview of trial numbers and their average enroll...Read More >>>

Published:
2018-07-31

Published by: Global Data

Prices Starting From:
$2500

Short Bowel Syndrome - Pipeline Review, H1 2018

Short Bowel Syndrome - Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome - Pipeline Review, H1 2018, provides an overview of the Short Bowel Syndrome (Gastrointestinal) pipeline landscape.Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the sma...Read More >>>

Published:
2018-06-12

Published by: Global Markets Direct

Prices Starting From:
$2000

Irritable Bowel Syndrome - Pipeline Review, H1 2018

Irritable Bowel Syndrome - Pipeline Review, H1 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H1 2018, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder that affects large intestine (colon). Sym...Read More >>>

Published:
2018-05-08

Published by: Global Markets Direct

Prices Starting From:
$2000

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018SummaryGlobalData's clinical trial report, “Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H1, 2018 provides an overview of Pelvic Inflammatory Disease (Pelvic Infections) clinical trials scenario. This report provides top line data relating to the clinical trials on Pelvic Inf...Read More >>>

Published:
2018-04-30

Published by: Global Data

Prices Starting From:
$2500

Global Inflammatory Bowel Disease Partnering 2012 to 2018

• Insight into key deal terms Read More >>>

Published:
2018-03-01

Published by: Current Partnering

Prices Starting From:
$1495

Global Irritable Bowel Syndrome Partnering 2012-2018

• Insight into key deal terms inRead More >>>

Published:
2018-03-01

Published by: Current Partnering

Prices Starting From:
$1495

Short Bowel Syndrome - Epidemiology Forecast to 2027

DelveInsight's Short Bowel Syndrome - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Short Bowel Syndrome epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered• United States• EU5 (Germany, France, Italy, Spain, and the United Kingdom)• Japan Study Period: 2016-2027 Short Bowel Sy...Read More >>>

Published:
2018-02-14

Published by: Delve Insight

Prices Starting From:
$3250

Irritable Bowel Syndrome (IBS) -Epidemiology Forecast to 2027

DelveInsight's Irritable Bowel Syndrome (IBS) - Epidemiology Forecast, 2027” report provides a comprehensive analysis of the Irritable Bowel Syndrome (IBS) epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Markets Covered• United States• EU5 (Germany, France, Italy, Spain, and the United Kingdom)• Japan Study Period: 2016-2...Read More >>>

Published:
2018-02-14

Published by: Delve Insight

Prices Starting From:
$3250

Autoimmune Disease Diagnosis Market by Products (Consumables, Assay Kits, Instruments, Services), Test Type (Inflammatory Markers, Autoantibodies), Disease (RA, SLE, Thyroiditis, Scleroderma), End Users (Hospitals, Clinical Labs) - Global Forecast to 2022

“The autoimmune disease diagnosis market projected to grow at a CAGR of 8.9% during the forecast period.”The global autoimmune disease diagnosis market is expected to reach USD 4.73 billion by 2022 from USD 3.09 billion in 2017, at a CAGR of 8.9%. Factors driving the growth of this market include the rising incidence of autoimmune diseases, growing healthcare expenditure, increasing access to ...Read More >>>

Published:
2018-01-29

Published by: MarketsandMarkets

Prices Starting From:
$5650

Global Ophthalmic Drugs Market Size Study, by Disease Type (Dry Eye Drugs, Retinal Disorders Drugs, Ophthalmic Anti-Allergy/Inflammatory/Infective Drugs, Anti-glaucoma Drugs), by Delivery Type (Capsules & Tablets, Gels, Eye drops, Eye Ointment, Eye Solutions), by Product Type (Prescription Drugs and Over-the-Counter Drugs), and Regional Forecasts, 2017-2025 (USD Billion/Million)

Global Ophthalmic Drugs Market industry valued approximately USD 23.21 billion in 2016 is anticipated to grow with a healthy growth rate of more than 5.27% over the forecast period 2017-2025. Rising frequencies of eye disorders like macular degeneration, presbyopia, and diabetic retinopathy among the most prevalent age groups are speculated to propel the growth.The objective of the study is to def...Read More >>>

Published:
2018-01-12

Published by: Bizwit Research and Consulting

Prices Starting From:
$3950

Global Inflammatory Bowel Disease Drugs Market Research Report Forecast 2017 to 2022

Delivery of the Report will take 2-3 working days once order is placed.The Global Inflammatory Bowel Disease Drugs Market Research Report Forecast 2017-2022 is a valuable source of insightful data for business strategists. It provides the Inflammatory Bowel Disease Drugs industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The ...Read More >>>

Published:
2017-12-18

Published by: S&P Consulting

Prices Starting From:
$2800

Irritable Bowel Syndrome - Pipeline Review, H2 2017

Irritable Bowel Syndrome - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H2 2017, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.Inflammatory Bowel Diseases (IBD) is a broad term that describes conditions with chronic or recurring immune respo...Read More >>>

Published:
2017-11-07

Published by: Global Markets Direct

Prices Starting From:
$2000

Global Inflammatory Bowel Disease Partnering 2010 to 2017

• Insight into key deal terms Read More >>>

Published:
2017-11-01

Published by: Current Partnering

Prices Starting From:
$1495

Global Irritable Bowel Syndrome Partnering 2010-2017

• Insight into key deal terms inRead More >>>

Published:
2017-11-01

Published by: Current Partnering

Prices Starting From:
$1495

Irritable Bowel Syndrome (IBS) -Epidemiology Forecast to 2025

DelveInsight “Irritable Bowel Syndrome (IBS) - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Irritable Bowel Syndrome (IBS) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Irritable Bowel Syndrome (IBS) prevalent or incident cases segmented by age, sex and subpopula...Read More >>>

Published:
2017-10-10

Published by: Delve Insight

Prices Starting From:
$2750

Short Bowel Syndrome - Epidemiology Insights to 2025

DelveInsight’s “Short Bowel Syndrome -Epidemiology Forecast, 2025” provides an overview of the epidemiology trends of Short Bowel Syndrome in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted data of Short Bowel Syndrome. The Report also discusses the prevailing risk factors, disease burden with special emphasis...Read More >>>

Published:
2017-07-31

Published by: Delve Insight

Prices Starting From:
$2950

Short Bowel Syndrome - Pipeline Review, H1 2017

Short Bowel Syndrome - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome - Pipeline Review, H1 2017, provides an overview of the Short Bowel Syndrome (Gastrointestinal) pipeline landscape.Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the sma...Read More >>>

Published:
2017-06-13

Published by: Global Markets Direct

Prices Starting From:
$2000

Malaysia Intravenous Immunoglobulin (IVIG) Market by Product Types (IgG, IgA, IgM, IgE and IgD), Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy, Primary Immune Thrombocytopenic Purpura, Inflammatory Myopathies, Specific Antibody Deficiency, Guillain-Barré Syndrome, Kawasaki Disease,

CHAPTER 1 INTRODUCTION1.1. REPORT DESCRIPTION1.2. KEY BENEFITS FOR STAKEHOLDERS1.3. KEY MARKET SEGMENTS1.4. RESEARCH METHODOLOGY1.4.1. Secondary research1.4.2. Primary research1.4.3. Analyst tools and modelsCHAPTER 2 EXECUTIVE SUMMARY2.1. CXO PERSPECTIVECHAPTER 3 MARKET OVERVIEW3.1. MARKET DEFINITION AND SCOPE3.2. OVERVIEW OF IVIG3.2.1. Patented products3.3. EPIDEMIOLOGY AND ECONOMIC BURDEN OF CHR...Read More >>>

Published:
2017-05-24

Published by: Allied Market Research

Prices Starting From:
$2850

Irritable Bowel Syndrome - Pipeline Review, H1 2017

Irritable Bowel Syndrome - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Irritable Bowel Syndrome - Pipeline Review, H1 2017, provides an overview of the Irritable Bowel Syndrome (Gastrointestinal) pipeline landscape.Inflammatory Bowel Diseases (IBD) is a broad term that describes conditions with chronic or recurring immune respo...Read More >>>

Published:
2017-05-23

Published by: Global Markets Direct

Prices Starting From:
$2000

Short Bowel Syndrome - Pipeline Review, H2 2016

Short Bowel Syndrome - Pipeline Review, H2 2016SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome – Pipeline Review, H2 2016, provides an overview of the Short Bowel Syndrome (Gastrointestinal) pipeline landscape.Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the s...Read More >>>

Published:
2016-12-14

Published by: Global Markets Direct

Prices Starting From:
$2000

Global Inflammatory Bowel Disease Partnering 2010 to 2016

Published:
2016-11-01

Published by: Current Partnering

Prices Starting From:
$1495

Global Irritable Bowel Syndrome Partnering 2010-2016

Published:
2016-11-01

Published by: Current Partnering

Prices Starting From:
$1495

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015

Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015SummaryGlobalData's clinical trial report, “Pelvic Inflammatory Disease (Pelvic Infections) Global Clinical Trials Review, H2, 2015 provides an overview of Pelvic Inflammatory Disease (Pelvic Infections) clinical trials scenario. This report provides top line data relating to the clinical trials on Pelvic Inf...Read More >>>

Published:
2015-12-30

Published by: Global Data

Prices Starting From:
$2500